Private asset managers across the region face distinct structural pressures alongside significant technology and risk management deficits, according to the latest general partner (GP) survey by MSCI.
Japan's defined benefit pensions are reluctant to fully return to domestic bonds despite higher rates, instead shifting toward general accounts and alternatives in pursuit of better yields, according to JP Morgan Asset Management's latest pension survey.
Life insurers are backing quality over risk as market conditions improve but uncertainty lingers. Our latest survey reveals where they're placing their most calculated bets and why flexible mandates are becoming the new playbook.
Institutional investors across Asia Pacific remain committed to increasing private markets allocations but they're showing clear preferences for developed markets, private credit and technology-enabled investments amid global uncertainties.
Asset owners and managers in Asia Pacific (APAC) are looking to domestic and regional bond markets for portfolio diversification and income, reveals a survey commissioned by State Street Investment Management’s ABF Pan Asia Bond Index Fund (PAIF).
Pension investors in the region outpaced global peers with artificial intelligence integration surpassing the 91% global average, a global investor survey finds. They also showed the greatest appetite for global equities.
Despite the impact of the Covid-19 pandemic on economies, more than $1 trillion flowed into ETFs globally in 2021, with a growing number of investors looking to invest in thematic varieties.
Investors are feeling confident in their strategies to counter potential rising inflation, interest rate hikes and higher stock, bond and currency volatility, according to a new survey by Natixis Investment Managers.
Asian institutional investors were generally more optimistic about post-pandemic economic recovery but only 33% were confident about achieving their short-term objectives.
Respondents to the monthly BoA Global Fund Manager Survey say that the pandemic is no longer their top tail-risk. It has been replaced by worries about rising prices.